Anne F Schott

Anne F Schott

UNVERIFIED PROFILE

Are you Anne F Schott?   Register this Author

Register author
Anne F Schott

Anne F Schott

Publications by authors named "Anne F Schott"

Are you Anne F Schott?   Register this Author

44Publications

1168Reads

27Profile Views

Factors influencing the use of extended adjuvant endocrine therapy.

Breast Cancer Res Treat 2019 May 31;175(1):181-189. Epub 2019 Jan 31.

Division of Oncology, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr., #5513, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-019-05145-8
Publisher Site
http://dx.doi.org/10.1007/s10549-019-05145-8DOI Listing
May 2019

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.

J Clin Oncol 2018 05 20;36(13):1317-1322. Epub 2018 Mar 20.

Reshma Jagsi, Felix Y. Feng, Corey Speers, Michael Sabel, Anne F. Schott, and Lori Pierce, University of Michigan; Kent A. Griffith, University of Michigan School of Public Health, Ann Arbor, MI; Jennifer R. Bellon and Beth Overmoyer, Dana-Farber Cancer Institute, Boston, MA; Wendy A. Woodward, The University of Texas MD Anderson Cancer Center, Houston, TX; Janet K. Horton, Duke University School of Medicine, Durham, NC; and Alice Ho, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.77.2665
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.77.2665DOI Listing
May 2018

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.

J Clin Oncol 2018 02 14;36(4):326-332. Epub 2017 Nov 14.

N. Lynn Henry and Anne F. Schott, University of Michigan, Ann Arbor, MI; N. Lynn Henry, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Joseph M. Unger, Anna Moseley, and Danika L. Lew, Southwest Oncology Group Statistical Center and Fred Hutchinson Cancer Research Center; Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Louis Fehrenbacher, Kaiser Permanente National Cancer Institute Community Oncology Research Program, Oakland, CA; Patrick J. Flynn, Metro Minnesota Community Clinical Oncology Program/Minnesota Oncology, St Louis Park, MN; Debra M. Prow, William R. Bliss Cancer Center, Ames, IA; Carl W. Sharer, Phoenixville Cancer Center, Phoenixville, PA; Gary V. Burton, Louisiana State University Health Science Center-Shreveport, Shreveport, LA; Charles S. Kuzma, FirstHealth of the Carolinas, Pinehurst, NC; Michael J. Fisch, AIM Specialty Health, Chicago, IL; Dawn L. Hershman, Columbia University, New York, NY; and James L. Wade III, Heartland National Cancer Institute Community Oncology Research Program, Decatur, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.6651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805479PMC
February 2018

Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer.

Authors:
Anne F Schott

JAMA Oncol 2016 08;2(8):1047-8

Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0446DOI Listing
August 2016

Personalized Medicine: Genomics Trials in Oncology.

Trans Am Clin Climatol Assoc 2015 ;126:133-43

Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530676PMC
June 2016

Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.

Breast Cancer Res Treat 2016 Feb 13;155(3):589-95. Epub 2016 Feb 13.

Internal Medicine/Hematology/Oncology, University of Michigan Medical School, 1500 East Medical Center Dr, Med Inn Bldg C450, Ann Arbor, MI, 48109-5843, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3705-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895232PMC
February 2016

The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.

Semin Oncol 2015 Oct 10;42(5):731-9. Epub 2015 Jul 10.

Division of Hematology and Oncology, Center for Personalized Therapy and Clinical Trials Office UC San Diego-Moores Cancer Center, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.07.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673983PMC
October 2015

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.

Clin Cancer Res 2015 Jun 7;21(11):2487-98. Epub 2014 Nov 7.

Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516625PMC
June 2015

Genome Medicine in Cancer: What's in a Name?

Cancer Res 2015 May 28;75(10):1930-5. Epub 2015 Apr 28.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0174DOI Listing
May 2015

Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?

J Natl Cancer Inst Monogr 2015 May;2015(51):36-9

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH, AFS).

View Article

Download full-text PDF

Source
https://academic.oup.com/jncimono/article-lookup/doi/10.1093
Publisher Site
http://dx.doi.org/10.1093/jncimonographs/lgv004DOI Listing
May 2015

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

J Clin Oncol 2014 Nov 2;32(31):3483-9. Epub 2014 Jun 2.

Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/06/02/JCO.2014.56
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.2561
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.2561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209100PMC
November 2014

Assessment of PIK3CA mutations in human epidermal growth factor receptor 2-positive breast cancer: clinical validity but not utility.

J Clin Oncol 2014 Oct 8;32(29):3207-9. Epub 2014 Sep 8.

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6132DOI Listing
October 2014

Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.

J Pain 2014 May 22;15(5):468-75. Epub 2014 Jan 22.

Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpain.2014.01.487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063362PMC
May 2014

Prediction of postchemotherapy ovarian function using markers of ovarian reserve.

Oncologist 2014 Jan 6;19(1):68-74. Epub 2013 Dec 6.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Department of Biostatistics, and Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903057PMC
January 2014

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.

Oncologist 2012 20;17(2):179-87. Epub 2012 Jan 20.

University of Michigan, Division of Hematology/Oncology, 24 Frank Lloyd Wright Drive, Suite A3400, PO Box 483, Ann Arbor, Michigan 48106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286166PMC
June 2012

Defining the benefits of neoadjuvant chemotherapy for breast cancer.

J Clin Oncol 2012 May 16;30(15):1747-9. Epub 2012 Apr 16.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.41.3161DOI Listing
May 2012

Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms.

Cancer 2011 Dec 20;117(24):5469-75. Epub 2011 Jun 20.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://deepblue.lib.umich.edu/bitstream/handle/2027.42/89530
Web Search
http://doi.wiley.com/10.1002/cncr.26230
Publisher Site
http://dx.doi.org/10.1002/cncr.26230DOI Listing
December 2011

Spatial registration of temporally separated whole breast 3D ultrasound images.

Med Phys 2009 Sep;36(9):4288-300

Department of Radiology, and Applied Physics Program, University of Michigan, Ann Arbor Michigan 48109, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1118/1.3193678
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749445PMC
http://dx.doi.org/10.1118/1.3193678DOI Listing
September 2009

Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.

J Natl Compr Canc Netw 2009 Feb;7(2):115-21

Division of Oncology, Stanford University, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2009.0011DOI Listing
February 2009

Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.

Ann Surg Oncol 2008 Nov 11;15(11):3252-8. Epub 2008 Sep 11.

Department of Surgical Oncology, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-0136-3DOI Listing
November 2008

Monitoring serial changes in circulating human breast cancer cells in murine xenograft models.

Cancer Res 2008 Jul;68(14):5529-32

Breast Oncology Program, Comprehensive Cancer Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0942, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-0630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789403PMC
July 2008

Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy.

Clin Cancer Res 2007 Jan;13(2 Pt 1):443-50

Department of Radiology, Center for Molecular Imaging, University of Michigan Medical School, Biomedical Sciences Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-1888DOI Listing
January 2007

Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.

Cancer Chemother Pharmacol 2006 Jul 8;58(1):129-35. Epub 2005 Nov 8.

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0132-2DOI Listing
July 2006

Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.

Ann Surg Oncol 2005 Sep 4;12(9):697-704. Epub 2005 Aug 4.

Department of Surgery, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan, 48109, USA.

View Article

Download full-text PDF

Source
http://www.springerlink.com/index/10.1245/ASO.2005.09.007
Publisher Site
http://dx.doi.org/10.1245/ASO.2005.09.007DOI Listing
September 2005

Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy.

J Ultrasound Med 2005 Jul;24(7):885-95

Department of Radiology, University of Michigan Health Systems, Ann Arbor, MI 48109-0326, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7863/jum.2005.24.7.885DOI Listing
July 2005

Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis.

Am J Surg Pathol 2005 Mar;29(3):354-8

Department of Pathology, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000152138.89395.fbDOI Listing
March 2005

Sentinel node biopsy prior to neoadjuvant chemotherapy.

Am J Surg 2003 Aug;186(2):102-5

Breast Oncology Program and Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0002-9610(03)00168-5DOI Listing
August 2003